1. Home >
  2. M&A >
  3. Venture >
  4. United States >
  5. California >
  6. TPG Invests In CardioDx

Venture • Life Science

TPG Invests In CardioDx

On May 11, 2011, private equity firm TPG invested in life science company CardioDx

Investment Context
  • This is TPG’s 25th transaction in the Life Science sector.
  • This is TPG’s 121st transaction in the United States.
  • This is TPG’s 40th transaction in California.
Investment Fate
  • CardioDx went public in 2013.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary
Date May 11, 2011
Target CardioDx
Sector Life Science
Investor(s) TPG
Deal Type Venture

Target Company

CardioDx

Redwood City, California, United States
CardioDx, Inc. is a molecular diagnostics company that serves cardiologists and their patients by offering clinically validated genomic tests to enhance patient care. The company is focused on the personalized management of patients with congestive heart failure, rhythm disturbances and atherosclerosis.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1992
PE ASSETS 296.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.

Deal Context for Investor #
Overall 177 of 453
Sector: Life Science 25 of 46
Type: Venture 43 of 93
State: California 40 of 88
Country: United States 121 of 299
Year: 2011 9 of 20
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-25 Confluent Medical

Scottsdale, Arizona, United States

Confluent Medical is a contract manufacturer of Nitinol-based and balloon catheter medical devices. Confluent provides a broad range of capabilities including developing and manufacturing components, delivery systems, and finished devices for medical device OEMs in many of the fastest-growing healthcare subsectors, including neurovascular, structural heart, electrophysiology, aortic intervention, peripheral vascular, and ENT. Confluent Medical was founded in 1991 and is based in Scottsdale, Arizona.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-16 RentPath

Norcross, Georgia, United States

RentPath, Inc. is a primary service is digital marketing for rental properties through a network of Internet listing websites, including Rent.com, ApartmentGuide.com, Rentals.com and Lovely.com. RentPath was founded in 1975 and is based in Norcross, Georgia.

Buy $525M

Explore Related M&A Activity

Life Science M&A - Venture M&A Deals - California M&A - United States M&A - 2011 M&A

Mergr

Solution for

Product

Company

Legal